

Hyderabad based HRV Pharma has emerged as a unique success story in the Indian pharmaceutical sector. Despite not owning a single manufacturing unit, the company generated a revenue of ₹650 crore to ₹700 crore during the last financial year. The company relies on its Drug Master Files (DMFs) and strong international client relationships and aims to achieve ₹1,000 crore in revenue in the coming years.
India has several Active Pharmaceutical Ingredient (API) manufacturers, with more than 650 companies approved by the US FDA or European GMP standards. However, many of these companies currently utilize only 50 to 55 percent of their manufacturing capacity. HRV Pharma Managing Director and CEO Hari Kiran Chereddy identified this gap as a major business opportunity.
The company has signed agreements with 53 manufacturing firms and supplies APIs to international clients through these partners. This model helps manufacturers improve capacity utilization while allowing HRV Pharma to generate hundreds of crores in revenue without owning a production facility. Industry experts compare this model to companies such as Uber, Ola, Swiggy, and Zomato, which operate through partner networks.














Comments (0)
No comments yet
Be the first to comment!